Tech Company Financing Transactions

Curebase Funding Round

On 5/5/2022, Curebase raised $40 million in Series B investment from Industry Ventures, aCrew Capital and Bold Capital Partners.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
This funding will deepen Curebase's breadth of capabilities beyond the virtual experience: via more complex site and community healthcare interfaces, a richer range of clinical software and services, and more robust capabilities for interventional drug sponsors and global studies.

Company Information

Company Status
Private & Independent
Healthcare IT
Mailing Address
335 S Van Ness Ave.
San Francisco, CA 94103
Email Address
Curebase's software technology and virtual staff enables recruitment and clinical data collection settings almost anywhere - from local clinics, to mobile care, telehealth, drive through sites, pharmacies and more. The most flexible decentralized clinical research solution.
Curebase LinkedIn Company Profile
Social Media
Curebase Company Twitter Account
Company News
Curebase News
Curebase on Facebook
Curebase on YouTube

Management Team

Email & Social
Chief Executive Officer
Thomas Lemberg
  Thomas Lemberg LinkedIn Profile  Thomas Lemberg Twitter Account  Thomas Lemberg News  Thomas Lemberg on Facebook



Browse more venture capital transactions:

Prev: 5/5/2022: Logseq venture capital transaction
Next: 5/5/2022: Alan venture capital transaction


Share this article


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary